5，Riddell S，Watanabe K，Goodrich J et al．Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones．Science，1992，257：238
6，Hazzan M，Labalette M，Noel C et al．Recall response to cytomegalovirus in allograft recipients．Transplantation，1997，63（5）：693
7，Walter E，Greenberg PD，Gilbert MJ et al．Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor．N Engl J Med，1995，333（16）：1038
8，Balfour HH，Jr CV Fletcher，A Erice et al．Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS．Antimicrob Agents Chemother，1996，40：2721
9，Craigen JL，Grundy JE．Cytomegalovirus induced up-regulation of LFA-1（CD58） and ICAM-1（CD54）is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment．Transplantation，1996，62（8）：1102
10，Bukowiski JF，Warner JF，Dennert G et al．Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo．J Immunol，1985，161：40
11，Biron CA，Byron KS，Sullivan JL．Severe herpesvirus infections in an adolescent without natural killer cells．N Engl J Med，1989，320：1731
12，Van den Berg AP，Van Son WJ，Janssen RAJ et al．Recovery from cytomegalovirus infection is associated with activation of peripheral blood lymphocytes．J Infect Dis，1992，166：128
13，Hengel H，Flohr T，Hammerling GJ et al．Human cytomegalovirus inhibits piptide translocation into the endoplasmic reticulum for MHC class I assembly．J Gen Virol，1996，77：2287
14，Wiertz EJHJ，Jones TR，Sun L et al．The human cytomegalovirus SU 11 gene product dislacates MHC class I heavy chain from the endoplasmic reticulum to the cytosol．Cell，1996，84：769
15，Browne H，Smith G，Beck S et al．A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin．Nature，1990，347：770
16，Reyburn HT，Mandelboim O，Vales-Gomez M et al．The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells．Nature，1997，386：514
17，Brayman KL，Dafoe DL，Smythe et al．Prophylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine．Arch Surg，1988，123：1502
18，He H，Rinaldo Jr CR，Morel PA et al．T cell proliferative responses to five human cytomegalovirus proteins in healthy seropositive individuals：implications for vaccine development．J Gen Virol，1995，76：1603
19，Khattab BAM，Lindenmaier W，Frank R et al．Three T-cell epitopes within the C-terminal 265 amino acids of the matrix protein pp65 of human cytomegalovirus recognized by human lymphocytes．J Med Virol，1997，52：68
20，Venema H，van den Berg AP，van Zanten C et al．Nature killer cell responses in renal transplant patients with cytomegalovirus infection．J Med Virol，1994，42：188
